Fasting diet and exercise may boost chemo in aggressive breast cancer

NCT ID NCT06831955

Recruiting now Disease control Sponsor: Universitaire Ziekenhuizen KU Leuven Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study tests whether adding a fasting-mimicking diet and exercise to standard chemotherapy and immunotherapy can improve treatment results for people with early-stage triple negative breast cancer. About 356 participants will be randomly assigned to receive either the lifestyle program plus standard treatment or standard treatment alone. The main goal is to see if the combination leads to a higher rate of complete tumor disappearance before surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING

Contacts and locations

Locations

AZ Groeninge
RECRUITING

Kortrijk, Belgium
Centre Hospitalier Universitaire (CHU) UCL Liège
RECRUITING

Liège, Belgium
Centre Hospitalier Universitaire (CHU) UCL Namur
RECRUITING

Namur, Belgium
Cliniques universitaires Saint-Luc (UCLouvain)
RECRUITING

Brussels, Belgium
Jessa Ziekenhuis Hasselt
RECRUITING

Hasselt, Belgium
UZ Antwerpen
RECRUITING

Antwerp, Belgium
UZ Brussel
RECRUITING

Brussels, Belgium
UZ Gent
NOT_YET_RECRUITING

Ghent, Belgium
University Hospital Leuven
RECRUITING

Leuven, Belgium
Ziekenhuis aan de Stroom
NOT_YET_RECRUITING

Antwerp, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.